Exosomal miR‐155‐5p Modulates Breast Cancer Proliferation and Metastasis Via NF‐κB Activation
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Rui Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs, Cell Proliferation, Exosomes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: This study was supported by the Scientific Research Project of Colleges and Universities in Anhui Province (No. 2023AH051916); Key Project of Natural Science F….
Abstract (Originalsprache)
Breast cancer (BC) represents a major contributor to cancer‐associated deaths among women, underscoring the need for novel therapeutic approaches. This study explores the role of miR‐155‐5p as an oncogenic driver in BC progression through a multi‐omics approach. Elevated miR‐155‐5p expression was observed in serum exosomes and tumor tissues, with its upregulation correlating with advanced pathological stages, lymph node metastasis, and unfavorable clinical outcomes. Functional experiments demonstrated that miR‐155‐5p enhances cellular proliferation, motility, and invasive capacity while inhibiting apoptosis in BC. Mechanistically, miR‐155‐5p exerts its effects by directly suppressing Nedd4 Family Interacting Protein 1 (NDFIP1), thereby initiating activation of the NF‐κB axis. This activation was characterized by increased nuclear translocation of NF‐κB p65 and enhanced secretion of inflammatory cytokines, including IL‐6 and TNF‐α. In vivo, knockdown of miR‐155‐5p effectively suppressed tumor growth and metastasis, with these effects reversed by silencing NDFIP1. These results highlight the miR‐155‐5p/NDFIP1/NF‐κB axis as a critical pathway in BC progression, providing new insights into its molecular mechanisms. miR‐155‐5p emerges as a promising diagnostic marker and therapeutic candidate, suggesting the feasibility of miRNA‐based interventions in BC treatment. This study highlights the pivotal role of integrative omics technologies in uncovering cancer‐related regulatory networks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
ORCID-Profile: Rui Xu
Förderung
- This study was supported by the Scientific Research Project of Colleges and Universities in Anhui Province (No. 2023AH051916); Key Project of Natural Science F…
Zitieren
APA
Xu, R., Guo, C. X., Qian, J., Yin, F. X., & Zhang, M. L. (2025). Exosomal miR‐155‐5p Modulates Breast Cancer Proliferation and Metastasis Via NF‐κB Activation. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70542
Vancouver
Xu R, Guo CX, Qian J, Yin FX, Zhang ML. Exosomal miR‐155‐5p Modulates Breast Cancer Proliferation and Metastasis Via NF‐κB Activation. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70542
BibTeX
@article{Xu2025,
author = {Xu, Rui and Guo, Chen-Xu and Qian, Jun and Yin, Fa-Xiang and Zhang, Ming-Liang},
title = {Exosomal miR‐155‐5p Modulates Breast Cancer Proliferation and Metastasis Via NF‐κB Activation},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70542}
}
EUVIMED